nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.066	0.066	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.0479	0.0479	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.0264	0.0264	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—CTGF—focal segmental glomerulosclerosis	0.0245	0.0245	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.0204	0.0204	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.0174	0.0174	CbGpPWpGaD
Clenbuterol—ADRB1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.016	0.016	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—AGTR1—focal segmental glomerulosclerosis	0.0159	0.0159	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.0153	0.0153	CbGpPWpGaD
Clenbuterol—TNF—Monoamine Transport—AGT—focal segmental glomerulosclerosis	0.0145	0.0145	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—AGTR1—focal segmental glomerulosclerosis	0.0145	0.0145	CbGpPWpGaD
Clenbuterol—ADRB1—Endothelin Pathways—EDN1—focal segmental glomerulosclerosis	0.0144	0.0144	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.0133	0.0133	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.0127	0.0127	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 trafficking events—AGTR1—focal segmental glomerulosclerosis	0.0125	0.0125	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.0121	0.0121	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.012	0.012	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—NOS2—focal segmental glomerulosclerosis	0.0118	0.0118	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP2—focal segmental glomerulosclerosis	0.0114	0.0114	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.0113	0.0113	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.011	0.011	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—SPP1—focal segmental glomerulosclerosis	0.0106	0.0106	CbGpPWpGaD
Clenbuterol—CYP1A1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.0104	0.0104	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.01	0.01	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.00941	0.00941	CbGpPWpGaD
Clenbuterol—ADRB3—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.00938	0.00938	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.00902	0.00902	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP9—focal segmental glomerulosclerosis	0.00857	0.00857	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.00842	0.00842	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.00841	0.00841	CbGpPWpGaD
Clenbuterol—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.00834	0.00834	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.00834	0.00834	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.00825	0.00825	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	0.0081	0.0081	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—TGFB1—focal segmental glomerulosclerosis	0.00809	0.00809	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	0.00798	0.00798	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.0077	0.0077	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.00769	0.00769	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00749	0.00749	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—SERPINE1—focal segmental glomerulosclerosis	0.00736	0.00736	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00719	0.00719	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00717	0.00717	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00698	0.00698	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—MMP9—focal segmental glomerulosclerosis	0.00689	0.00689	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	0.00672	0.00672	CbGpPWpGaD
Clenbuterol—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00664	0.00664	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.00637	0.00637	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00627	0.00627	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00626	0.00626	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00616	0.00616	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.00557	0.00557	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00554	0.00554	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00553	0.00553	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.00545	0.00545	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.0053	0.0053	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00528	0.00528	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00515	0.00515	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00502	0.00502	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00498	0.00498	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00497	0.00497	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00497	0.00497	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00491	0.00491	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00487	0.00487	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00484	0.00484	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.00474	0.00474	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00474	0.00474	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00469	0.00469	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.00468	0.00468	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFB1—focal segmental glomerulosclerosis	0.00465	0.00465	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.00458	0.00458	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00445	0.00445	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00445	0.00445	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00427	0.00427	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00418	0.00418	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00412	0.00412	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00402	0.00402	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00393	0.00393	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00379	0.00379	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00376	0.00376	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00366	0.00366	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.00364	0.00364	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00361	0.00361	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00358	0.00358	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.0035	0.0035	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.00343	0.00343	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00338	0.00338	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00333	0.00333	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00328	0.00328	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.00326	0.00326	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00321	0.00321	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00306	0.00306	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00303	0.00303	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.00302	0.00302	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00297	0.00297	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00291	0.00291	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.0029	0.0029	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00281	0.00281	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00279	0.00279	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00277	0.00277	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00272	0.00272	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00267	0.00267	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00265	0.00265	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00254	0.00254	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00251	0.00251	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.00249	0.00249	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00242	0.00242	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00231	0.00231	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0023	0.0023	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.0023	0.0023	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00223	0.00223	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00214	0.00214	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00211	0.00211	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00204	0.00204	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00202	0.00202	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00201	0.00201	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00195	0.00195	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.0019	0.0019	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00185	0.00185	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00185	0.00185	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00174	0.00174	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00173	0.00173	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00158	0.00158	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00157	0.00157	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00157	0.00157	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00153	0.00153	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0014	0.0014	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00132	0.00132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00128	0.00128	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00115	0.00115	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.0011	0.0011	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00108	0.00108	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.001	0.001	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000975	0.000975	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000959	0.000959	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000934	0.000934	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000932	0.000932	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000927	0.000927	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000912	0.000912	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.0009	0.0009	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000876	0.000876	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000859	0.000859	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000852	0.000852	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000852	0.000852	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000849	0.000849	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000844	0.000844	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000833	0.000833	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000831	0.000831	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000826	0.000826	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000799	0.000799	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000791	0.000791	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000773	0.000773	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00077	0.00077	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000757	0.000757	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000722	0.000722	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000711	0.000711	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00071	0.00071	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000694	0.000694	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000681	0.000681	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000649	0.000649	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000635	0.000635	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000613	0.000613	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.0006	0.0006	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000595	0.000595	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000592	0.000592	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000553	0.000553	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00055	0.00055	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000539	0.000539	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000534	0.000534	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000522	0.000522	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000509	0.000509	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000506	0.000506	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000495	0.000495	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000457	0.000457	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000453	0.000453	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000447	0.000447	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000434	0.000434	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000422	0.000422	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000416	0.000416	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000413	0.000413	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000391	0.000391	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000382	0.000382	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000374	0.000374	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000356	0.000356	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000352	0.000352	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000351	0.000351	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000344	0.000344	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000273	0.000273	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000269	0.000269	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000265	0.000265	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000263	0.000263	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000227	0.000227	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000222	0.000222	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000217	0.000217	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000174	0.000174	CbGpPWpGaD
